Translating Research for the Radiotheranostics of Nanotargeted 188Re-Liposome |
| |
| Authors: | Chih-Hsien Chang Ming-Cheng Chang Ya-Jen Chang Liang-Cheng Chen Te-Wei Lee Gann Ting |
| |
| Affiliation: | 1.Isotope Application Division, Institute of Nuclear Energy Research, Taoyuan 32546, Taiwan; (M.-C.C.); (Y.-J.C.); (L.-C.C.); (T.-W.L.); (G.T.);2.Department of Biomedical Imaging and Radiological Sciences, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan |
| |
| Abstract: | Nanoliposomes are one of the leading potential nano drug delivery systems capable of targeting chemotherapeutics to tumor sites because of their passive nano-targeting capability through the enhanced permeability and retention (EPR) effect for cancer patients. Recent advances in nano-delivery systems have inspired the development of a wide range of nanotargeted materials and strategies for applications in preclinical and clinical usage in the cancer field. Nanotargeted 188Re-liposome is a unique internal passive radiotheranostic agent for nuclear imaging and radiotherapeutic applications in various types of cancer. This article reviews and summarizes our multi-institute, multidiscipline, and multi-functional studied results and achievements in the research and development of nanotargeted 188Re-liposome from preclinical cells and animal models to translational clinical investigations, including radionuclide nanoliposome formulation, targeted nuclear imaging, biodistribution, pharmacokinetics, radiation dosimetry, radiation tumor killing effects in animal models, nanotargeted radionuclide and radio/chemo-combination therapeutic effects, and acute toxicity in various tumor animal models. The systemic preclinical and clinical studied results suggest 188Re-liposome is feasible and promising for in vivo passive nanotargeted radionuclide theranostics in future cancer care applications. |
| |
| Keywords: | liposome nanoliposome nuclear imaging radiotheranostics rhenium-188 |
|
|
